{"id":17751,"identifier":"DVN/W1M6OP","persistentUrl":"https://doi.org/10.7939/DVN/W1M6OP","protocol":"doi","authority":"10.7939","publisher":"UAL Dataverse","publicationDate":"2021-08-26","storageIdentifier":"file://10.7939/DVN/W1M6OP","datasetVersion":{"id":1739,"datasetId":17751,"datasetPersistentId":"doi:10.7939/DVN/W1M6OP","storageIdentifier":"file://10.7939/DVN/W1M6OP","versionNumber":1,"versionMinorNumber":0,"versionState":"RELEASED","lastUpdateTime":"2021-08-26T16:04:33Z","releaseTime":"2021-08-26T16:04:33Z","createTime":"2021-08-26T15:51:23Z","license":"CC0","termsOfUse":"CC0 Waiver","fileAccessRequest":false,"metadataBlocks":{"citation":{"displayName":"Citation Metadata","fields":[{"typeName":"title","multiple":false,"typeClass":"primitive","value":"Risk factors associated with severe outcomes of COVID-19: An updated rapid review to inform national guidance on vaccine prioritization in Canada"},{"typeName":"author","multiple":true,"typeClass":"compound","value":[{"authorName":{"typeName":"authorName","multiple":false,"typeClass":"primitive","value":"Pillay, Jennifer"},"authorAffiliation":{"typeName":"authorAffiliation","multiple":false,"typeClass":"primitive","value":"University of Alberta"}}]},{"typeName":"datasetContact","multiple":true,"typeClass":"compound","value":[{"datasetContactName":{"typeName":"datasetContactName","multiple":false,"typeClass":"primitive","value":"Pillay, Jennifer"},"datasetContactAffiliation":{"typeName":"datasetContactAffiliation","multiple":false,"typeClass":"primitive","value":"University of Alberta"},"datasetContactEmail":{"typeName":"datasetContactEmail","multiple":false,"typeClass":"primitive","value":"jpillay@ualberta.ca"}}]},{"typeName":"dsDescription","multiple":true,"typeClass":"compound","value":[{"dsDescriptionValue":{"typeName":"dsDescriptionValue","multiple":false,"typeClass":"primitive","value":"This file contain the data and excluded studies list for this rapid review."},"dsDescriptionDate":{"typeName":"dsDescriptionDate","multiple":false,"typeClass":"primitive","value":"2021-08-26"}}]},{"typeName":"subject","multiple":true,"typeClass":"controlledVocabulary","value":["Medicine, Health and Life Sciences"]},{"typeName":"keyword","multiple":true,"typeClass":"compound","value":[{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"risk factors"}}]},{"typeName":"publication","multiple":true,"typeClass":"compound","value":[{"publicationCitation":{"typeName":"publicationCitation","multiple":false,"typeClass":"primitive","value":"Gates M et al. Risk factors associated with severe outcomes of COVID-19: An updated rapid review to inform national guidance on vaccine prioritization in Canada. (Submitted to PLoSOpen)"}}]},{"typeName":"depositor","multiple":false,"typeClass":"primitive","value":"Pillay, Jennifer"},{"typeName":"dateOfDeposit","multiple":false,"typeClass":"primitive","value":"2021-08-26"}]}},"files":[{"label":"Covid RR update - data supporting conclusions - Aug 2021.xltm","restricted":false,"version":1,"datasetVersionId":1739,"dataFile":{"id":17753,"persistentId":"","pidURL":"","filename":"Covid RR update - data supporting conclusions - Aug 2021.xltm","contentType":"application/vnd.ms-excel.template.macroEnabled.12","filesize":635981,"storageIdentifier":"file://17b832689d5-7249bb2485ca","rootDataFileId":-1,"md5":"9c9b073be271303b507ef47061e60eb1","checksum":{"type":"MD5","value":"9c9b073be271303b507ef47061e60eb1"},"creationDate":"2021-08-26"}},{"label":"COVID RR update - Excluded studies list-2.xltm","restricted":false,"version":1,"datasetVersionId":1739,"dataFile":{"id":17754,"persistentId":"","pidURL":"","filename":"COVID RR update - Excluded studies list-2.xltm","contentType":"application/vnd.ms-excel.template.macroEnabled.12","filesize":284985,"storageIdentifier":"file://17b832ccc7c-f47e9c41e0fb","rootDataFileId":-1,"md5":"92a7849a4f0e20ef8f7a1cdea12aaee1","checksum":{"type":"MD5","value":"92a7849a4f0e20ef8f7a1cdea12aaee1"},"creationDate":"2021-08-26"}}],"citation":"Pillay, Jennifer, 2021, \"Risk factors associated with severe outcomes of COVID-19: An updated rapid review to inform national guidance on vaccine prioritization in Canada\", https://doi.org/10.7939/DVN/W1M6OP, UAL Dataverse, V1"}}